Terms: = Gastric cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Clinical Outcome
8 results:
1. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
Zhao H; Zhang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
[TBL] [Abstract] [Full Text] [Related]
2. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.
Openshaw MR; Richards CJ; Guttery DS; Shaw JA; Thomas AL
Expert Rev Mol Diagn; 2017 May; 17(5):459-470. PubMed ID: 28306358
[TBL] [Abstract] [Full Text] [Related]
3. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
Liu X; Guo W; Zhang W; Yin J; Zhang J; Zhu X; Liu T; Chen Z; Wang B; Chang J; Lv F; Hong X; Wang H; Wang J; Zhao X; Wu X; Li J
BMC Cancer; 2017 Mar; 17(1):188. PubMed ID: 28288572
[TBL] [Abstract] [Full Text] [Related]
4. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
Venturutti L; Cordo Russo RI; Rivas MA; Mercogliano MF; Izzo F; Oakley RH; Pereyra MG; De Martino M; Proietti CJ; Yankilevich P; Roa JC; Guzmán P; Cortese E; Allemand DH; Huang TH; Charreau EH; Cidlowski JA; Schillaci R; Elizalde PV
Oncogene; 2016 Dec; 35(48):6189-6202. PubMed ID: 27157613
[TBL] [Abstract] [Full Text] [Related]
5. SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling.
Xiong H; Wang J; Guan H; Wu J; Xu R; Wang M; Rong X; Huang K; Huang J; Liao Q; Fu Y; Yuan J
Oncol Rep; 2014 Oct; 32(4):1369-73. PubMed ID: 25109605
[TBL] [Abstract] [Full Text] [Related]
6. Genetic variants in the pi3k/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract] [Full Text] [Related]
7. Highly frequent pik3ca amplification is associated with poor prognosis in gastric cancer.
Shi J; Yao D; Liu W; Wang N; Lv H; Zhang G; Ji M; Xu L; He N; Shi B; Hou P
BMC Cancer; 2012 Feb; 12():50. PubMed ID: 22292935
[TBL] [Abstract] [Full Text] [Related]
8. gastric cancer in the era of molecularly targeted agents: current drug development strategies.
Arkenau HT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
[TBL] [Abstract] [Full Text] [Related]
